These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7492946)

  • 1. Intrathecal dynorphin-A infusion in rat spinal cord causes energy depletion, edema and neurologic dysfunction.
    Headrick JP; Faden AI; Vink R
    Neurochem Int; 1995 May; 26(5):489-95. PubMed ID: 7492946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
    Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: an experimental study in the rat using electrophysiological and morphological approaches.
    Winkler T; Sharma HS; Gordh T; Badgaiyan RD; Stålberg E; Westman J
    Amino Acids; 2002; 23(1-3):273-81. PubMed ID: 12373547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
    Long JB; Petras JM; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
    Bakshi R; Ni RX; Faden AI
    Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
    Faden AI
    Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
    Long JB; Mobley WC; Holaday JW
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
    Long JB; Petras JM; Holaday JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1169-77. PubMed ID: 2908046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in spinal cord injury: comparative experimental models.
    Faden AI; Jacobs TP; Smith GP; Green B; Zivin JA
    Peptides; 1983; 4(5):631-4. PubMed ID: 6657511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Receptor mechanism of dynorphin A in rat secondary spinal cord injuries].
    Li M; Yang Y; Hong X
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):290-3. PubMed ID: 8758278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dynorphin A (1-17) on motor function and spinal intracellular messenger systems in rat.
    Zhang Z; Li F; Ren M; Liu J
    Chin Med Sci J; 1996 Jun; 11(2):63-8. PubMed ID: 9387410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
    Long JB; Skolnick P
    Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW; Weinger MB; Yaksh TL
    Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
    Xue JC; Yu YX; Han JS; Jen MF
    Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length.
    Chen L; Huang LY
    J Pharmacol Exp Ther; 1998 Mar; 284(3):826-31. PubMed ID: 9495839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dynorphin A-induced antinociception at spinal level.
    Spampinato S; Candeletti S
    Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociception and paralysis induced by intrathecal dynorphin A.
    Herman BH; Goldstein A
    J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.